The ABHI teams up with ITN to explore the impact of tech on healthcare services, a COPD treatment receives CE marking, an NHS hospital begins using robotics in knee surgery, and UK cancer patients now have access to a treatment allowing clinicians to see the position and size of tumours in real time.
A new study says older diabetes patients would benefit from wearing glucose monitors, Baring Private Equity Asia is to buy Lumenis, over half of UK SMEs are ‘unprepared’ for Brexit despite further delay, and a UK AI company receives FDA clearance.
Celltrion Healthcare receive EU approval for their Remsima drug, Astellas purchases a gene therapy company for $3 billion, the ABPI recruit internally for their new CEO, could a ‘liquid health check’ predict disease risk, and has uncertainty lead to pharma innovation?
The BMA takes legal action against NHS Property Services over ‘unjustifiable’ rises in service charges, the NHS encourages its staff to get the free flu jab, the Conservative manifesto pledges to add 50,000 nurses in England by 2024-25, and NHS orthopaedic hospitals trial a support app.
NICE recommends Bayer’s MS treatment, complementary cancer therapies ‘do more harm than good’, Daiichi Sankyo announces results of Phase 3 CLEAR Wisdom trial, and could greater collaboration accelerate much-needed treatments for children with rare diseases?
The NIHR is to invest £34 million into global health research projects within low and middle-income countries, a ‘DIY’ alternative to traditional smear tests is ‘promising’, and the BBC shares 10 charts that show why the NHS does matter in the upcoming UK election.
A new healthtech research institute is to launch in Manchester, a molecular diagnostics player raises £12.3m to develop an instrument-free portfolio, Siemens acquires Corindus Vascular Robotics, and can Alexa be trusted with our health questions?
GSK agrees to divest rabies and tick-borne encephalitis vaccines, there’s further research into personalised breast cancer treatment, the finalists for the PT Sales Awards are revealed, and search results suggest consumers are at risk of buying fake pharma products online.
In the news this week: the CQC publishes its 2019 ‘State of Care’ report, the government proposes a new patient safety regulator, an inexpensive drug could ‘save thousands of lives a year’ from head injuries, and could British HIV-positive patients living in Spain lose their healthcare post-Brexit?
An innovation that combines data analytics and wearable technology to prevent falls is shortlisted in an awards category, the Axis-D pen-injector tech is to be licensed for development in diabetes treatment, and Northern Ireland’s Stormont is given £31m to prepare for a no-deal Brexit.